Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 725

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 5
Chunk 725
---
     294  
     28 
  
    Non-cash expense of ELOC commitment 
     1,048  
     - 
  
    Change in fair value of warrant liabilities 
     21,925  
     - 
  
    Change in fair value of convertible rights 
     (299) 
     - 
  
    Non-cash interest expense 
     302  
     - 
  
    Loss on extinguishment 
     1,472  
     - 
  
    Change in operating assets and liabilities: 

    Prepaid expenses and other current assets 
     (189) 
     369 
  
    R&D tax incentive receivable 
     5,579  
     (9,837)
  
    Trade and other payables 
     1,385  
     3,023 
  
    Net cash used in operating activities 
     (12,513) 
     (15,845)
  
    Cash flows from investing activities: 

    Purchase of property, plant and equipment 
     (8) 
     (277)
  
    Net cash used in investing activities 
     (8) 
     (277)
  
    Cash flows from financing activities: 

    Proceeds received from facility agreement 
     4,282  
     - 
  
    Repayment of facility agreement 
     (4,459) 
     - 
  
    Proceeds share issuance 
     48,343  
     - 
  
    Share issuance costs 
     (747) 
     - 
  
    Warrant issuance costs 
     (125) 
     - 
  
    Proceeds from issuance of convertible debt 
     2,779  
     - 
  
    Cancellation of warrants 
     (24,769) 
     - 
  
    Repayment of convertible debt 
     (3,795) 
     - 
  
    Debt issuance costs 
     (113) 
     - 
  
    Net cash provided by financing activities 
     21,396  
     - 
  
    Effect of exchange rate changes on cash and cash equivalents 
     306  
     (140)
  
    Net (decrease)/increase in cash and cash equivalents 
     8,875  
     (16,122)
  
    Cash and cash equivalents at beginning of period